To view the PDF file, sign up for a MySharenet subscription.

APN - Aspen Pharmacare Holdings Limited - Response to Bloomberg report regarding

Release Date: 01/12/2011 13:00
Code(s): APN
Wrap Text

APN - Aspen Pharmacare Holdings Limited - Response to Bloomberg report regarding the impact of the strike on Aspen`s H1 earnings ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) Registration number 1985/0002935/06 Share code: APN ISIN: ZAE000066692 ("Aspen" or "the Company") RESPONSE TO BLOOMBERG REPORT REGARDING THE IMPACT OF THE STRIKE ON ASPEN`S H1 EARNINGS Bloomberg`s reported after Aspen`s Annual General Meeting (AGM) this morning: "Aspen Pharmacare Holdings Ltd., the largest maker of generic drugs in the Southern Hemisphere, said a strike by workers in South Africa during its first half will have a "fairly severe" impact on earnings. Aspen Chief Executive Officer Stephen Saad commented at the company`s annual meeting of shareholders in Johannesburg today." This report is a consequence of a statement made by Stephen Saad, Aspen`s Group Chief Executive Officer, in response to a question from a shareholder at the AGM. To clarify this matter, Aspen wishes to advise that Mr. Saad told shareholders in attendance that it was extremely difficult to evaluate the financial consequences of the strike, given that some of the production lost had subsequently been recovered and sales lost during the period of the strike would have, at least, been partially recovered. Mr. Saad furthermore mentioned ZAR40 million in order to give context to the possible effect of the strike on operating profits. Investors were alerted to the fact that the strike had impacted performance at the final results presentations made in September 2011 and in the annual report published early in November 2011. Woodmead 1 December 2011 Sponsor: Investec Bank Limited Date: 01/12/2011 13:00:01 Supplied by www.sharenet.co.za Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Share This Story